What is an FDA warning letter, and how should your company respond once it has received one? In today's episode, Darshan Kulkarni talks with former FDA inspector Patrick Stone about the auditing process in compounding pharmacies, and how companies...
What tools should you use when starting a pharmaceutical company? Join former pharmacist Darshan Kulkarni as he talks about a few online tools that startup pharmaceutical companies may find useful. Plus, how to use tools such as Trello to track the...
What should you do after getting a PharmD degree? In this episode, Darshan talks about the most useful degrees pharmacists can get after recieving their doctorate in pharmacy, and how these degrees can translate into new careers in the life sciences.
Transparency, or the practice of disclosing clinical trial data, is highly important in clinical research. What happens when companies decide to not publish all of their clinical trial results, and fall out of compliance with the FDAA? FDA...
What are the four branches of patient centricity, and how can they apply to your company? In this episode, Darshan Kulkarni explains how companies can foster patient centricity through privacy, transparency, innovation and access. Plus, how the FDA...
Often, clinical trial results do not end up being disclosed. How can companies address this lack of transparency in clinical research? Darshan Kulkarni investigates the four ways in which health care companies can improve data transparency while...
